Advisory board member
Lee is an experienced senior executive, director, and investor within the cell and gene therapy sector. His management experience includes C-suite, senior management and Board roles in public and private biotech companies as well as non-profit organizations. He has also provided a wide range of contract management and strategic advisory services to bio-pharma, tools, technology and services companies in Canada, the United States, Middle East, Japan, and Europe.
Lee’s deepest expertise is in the cell therapy and regenerative medicine sectors within advanced therapies. He is the Managing Director of the Cell Therapy Group, a consultancy he formed in 2008 and which now operates within HighMont Adviors, Inc – a strategic management consulting company of which is a founding shareholder and Director. To any project he works on, Lee brings extensive deal-negotiating and structuring experience, strong technical knowledge, operational expertise, and a well-developed network of relationships within pharma-biotech and investment communities around the globe. He serves on numerous advisory boards and is a frequently-invited speaker and commentator on the advanced therapies industry.
Lee holds a Bachelors of Education and a JD from the University of British Columbia.